Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
Tamara Y. Milder, Sophie L. Stocker, Richard O. Day, Jerry R. Greenfield
Topics & Concepts
MedicineDiabetic ketoacidosisIntensive care medicineCanagliflozinKidney diseaseDiabetes mellitusType 2 diabetesPopulationKetoacidosisNephrologyDiseaseGlycosuriaInternal medicineType 1 diabetesEndocrinologyEnvironmental healthDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research